| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 30 May 2026 | 23 May 2026 |
| Centenial Surgical Suture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve 1) To approve Standalone Audited Financial Results along with Auditors Report for the quarter and year ended on March 31 2026 pursuant to Regulation 33 of SEBI (LODR) Regulations 2015. 2) Any other business with the permission of chair. The approved results will be uploaded on BSE Limited website after conclusion of the said meeting. | ||
| Board Meeting | 12 Feb 2026 | 7 Feb 2026 |
| Centenial Surgical Suture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve 1. Standalone Un-Audited Financial Results for the quarter ended on December 31 2025 pursuant to Regulation 33 of SEBI (LODR) Regulation 2015. 2. Any other business with the permission of chair. PFA (As Per BSE Announcement Dated on 12.02.2026) | ||
| Board Meeting | 13 Nov 2025 | 6 Nov 2025 |
| Quarterly Results; Centenial Surgical Suture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve 1. To approve Standalone Un-Audited Financial Results for the quarter and half year ended on September 30, 2025 pursuant to Regulation 33 of SEBI (LODR) Regulation, 2015. 2. Any other business with the permission of chair. Standalone Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2025 With reference to the above captioned subject, we wish to inform you that the Board of Directors at their meeting held on Thursday, November 13, 2025 approved the following: 1). Standalone Un-Audited Financial Results for the quarter and half year ended September 30, 2025 as per Regulation 33 of SEBI (LODR) Regulations, 2015. 2). Statement of Assets and Liabilities for the half year ended September 30, 2025. 3). Cash Flow Statement for the half year ended September 30, 2025. The said meeting commenced at 06:00 p.m. and concluded at 06:25 p.m. Kindly take the same on your record. (As Per BSE Announcement Dated on: 13/11/2025) | ||
| Board Meeting | 12 Aug 2025 | 5 Aug 2025 |
| Centenial Surgical Suture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve 1. To approve Standalone Un-Audited Financial Results for the quarter ended on June 30 2025 pursuant to Regulation 33 of SEBI (LODR) Regulation 2015. 2. Any other business with the permission of chair. With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Tuesday, August 12, 2025 approved the following: 1). Standalone Un-Audited Financial Results for the quarter ended June 30, 2025 as per Regulation 33 of SEBI (LODR) Regulations, 2015. The meeting commenced on 06.30 p.m. & concluded at 06.45 p.m. (As per BSE Announcement Dated on 12/08/2025) | ||
| Board Meeting | 21 Jun 2025 | 18 Jun 2025 |
| Centenial Surgical Suture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/06/2025 inter alia to consider and approve 1. To consider & approve re-appointment of M/s. Mahesh Chandra & Associates Chartered Accountants (ICAI Firm Reg No. 112334W) as a Statutory Auditors to hold office for a second term of 5 consecutive years subject to the approval of the Shareholders at the ensuing AGM. 2. To consider & approve appointment of M/s. HSPN & Associates LLP secretarial auditor for 5 years subject to approval of shareholders in the ensuing AGM. 3. To consider & approve re-appointment of Internal Auditor for the FY 2025-26. 4. To consider & approve re-appointment of Vijay Majrekar Managing Director (DIN : 00804808) for further 3 years subject to approval of shareholders in the ensuing AGM. 5. To consider & approve the Notice of 30th AGM. 6. To consider & approve the Directors Report as on 31/03/2025. 7. To approve the book-closure dates as per Reg 42 of SEBI (LODR) Regns 2015 for the purpose of 30th AGM. 8. To fix the Date Time & Venue for convening 30th AGM & approve the Draft Notice for the same. PFA (As Per BSE Announcement Dated on 21/06/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
